Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: A retrospective analysis

BACKGROUND AND AIM: The aim of this study was to investigate the prognostic relevance of plasma amylase and lipase concerning survival of patients suffering from metastatic pancreatic cancer (PC). METHOD: This retrospective study included 351 patients with metastatic PC, who were treated in a single...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Wien Klin Wochenschr
Autors principals: Asamer, Eva, Szkandera, Joanna, Gibiser, Paul, Lembeck, Anna Lena, Stojakovic, Tatjana, Kornprat, Peter, Lackner, Caroline, Winder, Thomas, Schlick, Konstantin, Stöger, Herbert, Gerger, Armin, Pichler, Martin, Stotz, Michael
Format: Artigo
Idioma:Inglês
Publicat: Springer Vienna 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209010/
https://ncbi.nlm.nih.gov/pubmed/30132196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-018-1383-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars